Journal profile · Surgery
EJSO
ISSN 0748-7983 · eISSN 1532-2157 · W.B. Saunders Ltd · ENGLAND · Monthly · Founded 1985
EJSO: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.36; hybrid open access; APC about USD 3,810; median 85 days to acceptance (171 articles, last 24 months); community-reported acceptance: easy (Elsevier website: 35%); 1,560 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
EJSO is published by W.B. Saunders Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Breast Implant and Reconstruction and Colorectal Cancer Surgical Treatments, together about 29.7% of its articles. Its main subfields are Surgery and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery. The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence. The Editors welcome submissions on clinical research and all other aspects of surgical oncology which advance the care of patients with cancer, including surgical quality control, epidemiology, preventative aspects of surgical oncology, as well as translational research relevant to surgical oncology practice.We offer many author benefits including Your Paper, Your Way (YPYW). YPYW is an easier submission process, focusing on the quality of the science in the initial stages of submission and only requiring elements needed for eventual production at the revision stage. Please refer to the Guide for Authors for further information.
From the journal's Aims & Scope
Research area (LetPub): Surgery
Editor-in-chief Riccardo A. AudisioPublisher website
Editorial board by country: 2 in mainland China (about 2%); most named United Kingdom 23, Italy 22, United States 19, Netherlands 10, Germany 7 (129 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology14.5%
- Breast Implant and ReconstructionMedicine7.9%
- Colorectal Cancer Surgical TreatmentsMedicine7.4%
- Breast Lesions and CarcinomasMedicine7%
- Gastric Cancer Management and OutcomesMedicine6%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine4.8%
- Intraperitoneal and Appendiceal MalignanciesMedicine4.4%
- Global Cancer Incidence and ScreeningMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Surgery | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Surgery | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Surgery | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.36LetPub ·
- Impact factor (publisher)
- 3.5Publisher website ·
- CiteScore 2026-06
- 5.1LetPub ·
- CiteScore (publisher)
- 5.1Publisher website ·
- SJR 2026-06
- 1.06LetPub ·
- SNIP 2026-06
- 1.26LetPub ·
- h-index
- 89LetPub ·
- h-index
- 147OpenAlex ·
- i10-index
- 5,062OpenAlex ·
- 2-year mean citedness
- 1.03OpenAlex ·
- Self-citation rate
- 8.6%LetPub ·
- Share of gold OA articles
- 23.29%LetPub ·
Volume
- Articles per year
- 586LetPub ·
Articles by year OpenAlex count · 21,114 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 791 | 182 | 155 |
| 2025 | 1,560 | 266 | 1,571 |
| 2024 | 2,164 | 237 | 2,926 |
| 2023 | 1,181 | 213 | 3,652 |
| 2022 | 1,111 | 207 | 4,051 |
| 2021 | 841 | 232 | 7,789 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
85 daysMedian, submission to acceptance · P25–P75 59 days – 129 days
- Acceptance to online
- median 1 days (171 articles)
- Submission to online
- median 90 days
- Sample
- 171 articles with submission and acceptance dates (1,364 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- 35%LetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- First decision after review
- 41 daysPublisher website ·
- Submission to acceptance
- 78 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,810 / EUR 3,480 / GBP 3,050 / JPY 472,550 | — | — | |
| Publisher website | USD 3,810 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteArticle types accepted13, with length limits
- case reportEditorials. These may be proffered on any subject of relevance to surgical oncology. Editorials should offer informed comment on an issue of topical interest an…Length not stated
- correspondenceEditorials. These may be proffered on any subject of relevance to surgical oncology. Editorials should offer informed comment on an issue of topical interest an…Length not stated
- editorialEditorials. These may be proffered on any subject of relevance to surgical oncology. Editorials should offer informed comment on an issue of topical interest an…main text ≤ 1,500 words
- editorialsEditorials. These may be proffered on any subject of relevance to surgical oncology.Length not stated
- for debate articlesFor Debate Articles. The Editors encourage the submission of well-written and well-argued articles For Debate on controversial issues of technique, practice or …Length not stated
- letters to the editorEditorials. These may be proffered on any subject of relevance to surgical oncology. Editorials should offer informed comment on an issue of topical interest an…Length not stated
- meta-analysisEditorials. These may be proffered on any subject of relevance to surgical oncology. Editorials should offer informed comment on an issue of topical interest an…Length not stated
- original articleEditorials. These may be proffered on any subject of relevance to surgical oncology. Editorials should offer informed comment on an issue of topical interest an…main text ≤ 3,000 words
- original articlesOriginal Articles. These will be considered on all aspects of surgical oncology.Length not stated
- reviewEditorials. These may be proffered on any subject of relevance to surgical oncology. Editorials should offer informed comment on an issue of topical interest an…main text ≤ 5,000 words
- review articleEditorials. These may be proffered on any subject of relevance to surgical oncology. Editorials should offer informed comment on an issue of topical interest an…Length not stated
- review articlesReview Articles. Narrative, systematic reviews and meta-analyses will be considered on all aspects of surgical oncology.Length not stated
- systematic reviewEditorials. These may be proffered on any subject of relevance to surgical oncology. Editorials should offer informed comment on an issue of topical interest an…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use The use and declaration of AI and AI-assisted technologies i
Where authors use artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should:Only use these technologies to improve readability and language, and to assist in the examination of data. They should not replace the key researcher tasks of explaining the interpretation of data and drawing valid scientific conclusions.Apply the technology with human oversight and c…
Source ↗Publisher website ·- Authorship Author contributions
For transparency, we encourage corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administratio…
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized peer review process. Model summary
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprints
Preprints can be shared anywhere at any time. Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1985
- ISSN
- 0748-7983
- Electronic ISSN
- 1532-2157
- Society / sponsor
- European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about EJSO
What CAS zone is EJSO in?
In the 2025 upgraded edition of the CAS Journal Ranking, EJSO is in Zone 2 of Medicine, and in Zone 2 of the minor category Oncology / Surgery. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of EJSO?
The latest impact factor listed by LetPub is 3.36; CiteScore 5.1, h-index 147.
How long does peer review take at EJSO?
Based on the dates recorded on 171 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 85 days (interquartile range 59–129 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy (Elsevier website: 35%)”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of EJSO based?
Of the 129 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United Kingdom (23), Italy (22) and United States (19). Counted from the institutions listed on the board page; for reference only.
Which databases index EJSO?
According to LetPub and DOAJ records, EJSO is indexed in SCIE and Scopus.
Is EJSO open access, and what is the APC?
EJSO is a hybrid journal. For open-access publication: APC about USD 3,810.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .